title: Enophthalmos and choroidal atrophy after intraophthalmic artery chemotherapy for retinoblastoma.
authors.affiliation: Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee; Department of Surgery, Division of Ophthalmology, St. Jude Children's Research Hospital, Memphis, Tennessee.
authors.forename: Brian C
authors.initials: BC
authors.lastname: Tse
authors.affiliation: Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Radiology, University of Tennessee Health Science Center, Memphis, Tennessee; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
authors.forename: Sue C
authors.initials: SC
authors.lastname: Kaste
authors.affiliation: Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
authors.forename: Rachel
authors.initials: R
authors.lastname: Brennan
authors.affiliation: Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
authors.forename: Brent
authors.initials: B
authors.lastname: Orr
authors.affiliation: Department of Ophthalmology, Hamilton Eye Institute, University of Tennessee Health Science Center, Memphis, Tennessee; Department of Surgery, Division of Ophthalmology, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: mwilson5@uthsc.edu.
authors.forename: Matthew W
authors.initials: MW
authors.lastname: Wilson
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage / Q000009:adverse effects; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001284:Atrophy; D010478:Chemotherapy, Cancer, Regional Perfusion / Q000009:adverse effects*; D002829:Choroid / Q000473:pathology; D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D003131:Combined Modality Therapy; D004200:Diseases in Twins; D015841:Enophthalmos / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D007223:Infant; D017075:Laser Coagulation; D008279:Magnetic Resonance Imaging; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D009880:Ophthalmic Artery; D019572:Retinal Neoplasms / Q000188:drug therapy*; D012175:Retinoblastoma / Q000188:drug therapy*; D015423:Scleritis / Q000139:chemically induced / Q000175:diagnosis; D059004:Topoisomerase I Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D019772:Topotecan / Q000008:administration & dosage / Q000009:adverse effects; D014430:Twins, Monozygotic
chemical_list: D018906:Antineoplastic Agents, Alkylating; D059004:Topoisomerase I Inhibitors; D019772:Topotecan; D008558:Melphalan